Residual benign prostatic glands at the urethrovesical anastomosis after radical retropubic prostatectomy:: Prediction and impact on disease outcome

被引:23
作者
Paul, R [1 ]
Hoppmann, M [1 ]
van Randenborgh, H [1 ]
Kübler, H [1 ]
Alschibaja, M [1 ]
Günther, M [1 ]
Hartung, R [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-81675 Munich, Germany
关键词
prostate cancer; radical prostatectomy; prognosis; surgical margins; benign prostatic glands;
D O I
10.1016/j.eururo.2004.04.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: Biochemical failure after radical prostatectomy (RP) for localized prostate cancer (PC) is the first evidence of disease recurrence. If residual benign prostatic glands are left behind on RP a theoretical PSA production from benign glands or residual neoplastic tissue could explain PSA failure. This study investigates the prediction and impact on disease outcome of residual benign glands at the urethrovesical anastomosis. Material and methods: 802 patients who underwent RP were retrospectively evaluated with special focus on residual benign glands (B+) at the urethrovesical anastomosis. B-status was defined from a biopsy of the urethral stump at 9, 12 and 3 o'clock position. Results: From 802 patients 73.6% were classified as B+, 26.4% B0. 92.0% of B+ patients demonstrated only isolated glands (B 1), 8.0% showed abundant glands (132). There was no difference in disease outcome for B0 and B+ patients. Patients with early PC who are candidates for nerve sparing procedures are more likely for B+ status. Conclusions: Benign prostatic glands at the apical margin of the RP specimen are a common finding, but neither isolated nor abundant glands have an impact on disease outcome. We think that a precise apical dissection to improve continence rates is possible, although these patients are at risk for residual benign tissue at the apex. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 12 条
  • [1] Augustin H, 2003, Minerva Urol Nefrol, V55, P251
  • [2] Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy
    Blute, ML
    Bergstralh, EJ
    Iocca, A
    Scherer, B
    Zincke, H
    [J]. JOURNAL OF UROLOGY, 2001, 165 (01) : 119 - 125
  • [3] Djavan B, 2000, J UROL A, V163, P624
  • [4] Prostate cancer: radical prostatectomy
    Nelson, JB
    Lepor, H
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (04) : 703 - +
  • [5] Natural history of progression after PSA elevation following radical prostatectomy
    Pound, CR
    Partin, AW
    Eisenberger, MA
    Chan, DW
    Pearson, JD
    Walsh, PC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1591 - 1597
  • [6] Ravery V, 1999, Semin Urol Oncol, V17, P127
  • [7] Ravery V, 1996, Prog Urol, V6, P981
  • [8] Prognostic significance of tumor volume after radical prostatectomy: A Multivariate analysis of pathological prognostic factors
    Salomon, L
    Levrel, O
    Anastasiadis, AG
    Irani, J
    De La Taille, A
    Saint, F
    Vordos, D
    Cicco, A
    Hoznek, A
    Chopin, D
    Abbou, CC
    [J]. EUROPEAN UROLOGY, 2003, 43 (01) : 39 - 44
  • [9] Benign prostatic glands at surgical margins of radical prostatectomy specimens: Frequency and associated risk factors
    Shah, R
    Bassily, N
    Wei, J
    Mucci, NR
    Montie, JE
    Sanda, MG
    Rubin, MA
    [J]. UROLOGY, 2000, 56 (05) : 721 - 725
  • [10] RADICAL PROSTATECTOMY WITH PRESERVATION OF SEXUAL FUNCTION - ANATOMICAL AND PATHOLOGICAL CONSIDERATIONS
    WALSH, PC
    LEPOR, H
    EGGLESTON, JC
    [J]. PROSTATE, 1983, 4 (05) : 473 - 485